Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |